Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  INDUSTRY >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Accounting
Advertising & marketing
Advertising industry
Aerospace & defense
Agriculture
Airline industry
Automotive industry
Banking
beverage related
Biological sciences
Biotech
Book publishing
Broadcasting industry
Business
Cable industry
Cancer
Charities
Chemicals industry
Climate change
Clothing industry
Coal industry
Commodities
Communications equipment
Computer games
Computer security
Computer services
Construction
Corporate finance
Corporate governance
Crime & Punishment
CRM
Database industry
Derivatives
Developer
Digital television
Drinks & beverage industry
Durable goods
E-commerce
Economics
Electronics
Emerging markets
Energy
Engineering Industry
Enterprise computing
Entrepreneur
Environment
Equity markets
Fashion
Fed watch
Finance related
Firearms industry
Fitness
Food and drink
Food industry
Forex markets
Fund management
Gaming
Genetics
government: general
Graphics industry
Handhelds
Healthcare
Horse racing
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
International development
International Paper Company
International relations
Internet news
IP and patents
IPO
Java
Job markets
Journalism
Knowledge management
Law
Leisure goods
Linux
Logistics
Management
Manufacturing
Marketing
Media
Medical
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Nanotechnology
Newspaper publishing
Oil & gas
Online access
Online broker
Online content
Online information
Online marketing
Online portals
Open source
OS news
Outdoor recreation
Outsourcing
Packaging & paper
Paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Police
Pop music
Public health
Real Estate industry
Recreation
Religion
Retail investor
Retail sector
RFID
Robotics
RSS
Science
Search Engines
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Space science
Steelmaking
Tech stocks
Technology
Telecom industry
television: general
Textiles
Tobacco industry
Trade
Transportation industry
Travel & Vacation
Travel industry
US banking
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Wireless sector
XML & metadata
 
 



Basilea reports topline results of isavuconazole phase 3 study in candidemia and   Download free Congoo NetPass for access - 18 Hours ago
Basilea Pharmaceutica AG / Basilea reports topline results of isavuconazole phase 3 study in candidemia and other invasive Candida infections . Processed and transmitted by NASDAQ OMX Corporate Solutions.
all 6 news articles >>
  
    



Inotek Pharmaceuticals Announces Conversion of $21 Million Principal Amount of 5.0%   - 11 Hours ago
LEXINGTON, Mass.--(BUSINESS WIRE)-- Inotek Pharmaceuticals Corporation (NASDAQ: ITEK) (the “Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization
  
    




Zogenix Prices Public Offering of Common Stock   - 10 Hours ago
(GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing unique therapies for the treatment of central nervous system (CNS) disorders, announced today that
all 2 news articles >>
  
    



REG-Form 8.3 - Perrigo Company plc   - 11 Hours ago
Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
all 86 news articles >>
  
    



Pacira Pharmaceuticals, Inc. Reports Second Quarter 2015 Financial Results   - 11 Hours ago
Conference Call Today at 9 a.m. ET PARSIPPANY, N.J.--(BUSINESS WIRE)--Jul. 30, 2015-- Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updates on EXPAREL™ (bupivacaine liposome injectable suspension)
  
    



Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement   - 11 Hours ago
Charles River Laboratories and AstraZeneca Renew Strategic Partnership Agreement - Leading Global CRO and Global Biopharmaceutical Company Extend Relationship to Accelerate Drug Development
all 1 news articles >>
  
    


American Express takes you places Sponsored
The Preferred Rewards Gold Card takes you places. And shows you’ve arrived. Enjoy Gold Card benefits and access while you earn travel rewards fast. Earn 10,000 Membership Rewards® bonus points redeemable for rewards after your first purchase.  Learn More



Neos Therapeutics Resubmits New Drug Application for FDA Review of Amphetamine Extended-Release   - 12 Hours ago
DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)-- Neos Therapeutics, Inc. (NASDAQ: NEOS), a pharmaceutical company with a late-stage pipeline of innovative extended-release (“XR”) product candidates for the
  
    



Agios to Webcast Conference Call of Second Quarter 2015 Financial Results on August   - 12 Hours ago
(GLOBE NEWSWIRE) -- Agios Pharmaceuticals The live webcast can be accessed under "Events and Presentations" in the Investors and Media section of the company's website at www.agios.com. The conference
  
    



Threshold Pharmaceuticals Reports Second Quarter 2015 Financial and Operational   - 12 Hours ago
SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/30/15 -- Threshold Pharmaceuticals "We are pleased with progress being made in the development programs for both of our product candidates, evofosfamide
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric   - 12 Hours ago
/PRNewswire/ -- Ascendis Pharma A/S "We are extremely pleased with the top-line results from our Phase 2 pediatric study and believe these data establish once-weekly TransCon Growth Hormone as the potential
  
    



Threshold Pharmaceuticals Reports Second Quarter 2015 Financial and Operational   - 11 Hours ago
SOUTH SAN FRANCISCO, CA--(Marketwired - Jul 30, 2015) - Threshold Pharmaceuticals, Inc. ( NASDAQ : THLD ) today reported financial results for the second quarter 2015. Revenue for the second quarter
all 1 news articles >>
  
    



NeuWave Medical Inc., Receives FDA Clearance for Ablation Confirmation Software   - 12 Hours ago
- First and Only, Integrated In-Procedure Confirmation for Ablation of Soft Tissue Lesions - MADISON, Wis. & MINNEAPOLIS--(BUSINESS WIRE)--Jul. 30, 2015-- NeuWave Medical™ Inc., a privately held medical
all 1 news articles >>
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



Alkermes plc Reports Second Quarter 2015 Financial Results   - 12 Hours ago
"" Second Quarter Revenues of $151.4 Million and Non-GAAP Diluted Loss Per Share of $0.09 "" "" Alkermes Unveils ARISTADA™ as Proposed Brand Name for Aripiprazole Lauroxil; Final Launch Preparations
  
    



Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference   - 12 Hours ago
HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology
  
    



NeuWave Medical gets FDA OK for software to pair with its cancer-fighting device   - 12 Hours ago
July 30--For more than four years, NeuWave Medical's Certus 140 system has been used at hospitals around the U.S. to attack lesions and cancerous tumors through ablation, destroying them with microwave
  
    



Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year   - 11 Hours ago
Teva Reports Strong Second Quarter 2015 Results and Raises Guidance for Full-Year 2015 Revenues of $5.0 billion, in line with the second quarter of 2014. Non-GAAP operating income of $1.6
  
    



Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing   - 11 Hours ago
Charles River Laboratories Announces Second-Quarter 2015 Results from Continuing Operations – Second-Quarter Revenue of $339.6 Million – – Second-Quarter GAAP Earnings per Share of $1.02
  
    



Cerulean to Host Second Quarter 2015 Conference Call on August 6   - 11 Hours ago
Cerulean Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting TM , today announced it will provide an update on corporate activities for the second quarter 2015 on August
  
    



Alexion Reports Second Quarter 2015 Results   - 12 Hours ago
Soliris™ (eculizumab) Net Product Sales of $636 Million; Increased 24% Year-on-Year Despite Currency Headwinds; 31% Volume Increase Year-on-Year 2015 Revenue Guidance Increased Reflecting Strong Growth
all 2 news articles >>
  
    



Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests,   - 12 Hours ago
/PRNewswire/ -- ReportsnReports.com adds cancer diagnostics market 2015 research reports analyzing tumor biomarker tests, imaging, endoscopy and biopsy as well as providing forecasts for the global industry
  
    



Synergy Pharmaceuticals Announces Positive Results in the Second Phase 3 Trial of   - 13 Hours ago
NEW YORK--(BUSINESS WIRE)--Jul. 30, 2015-- Synergy Pharmaceuticals Inc Preliminary analysis of the data indicates that both plecanatide 3.0 mg and 6.0 mg doses met the study's primary endpoint and demonstrated
  
    



Sainsbury's and Celesio form pharmacy partnership   - 12 Hours ago
J Sainsbury Plc (Sainsbury's) and Celesio AG, owner of Lloyds Pharmacy Ltd (LloydsPharmacy), today announce the formation of a strategic partnership that will see LloydsPharmacy acquire Sainsbury's pharmacy
  
    



Trading Amgen ahead of earnings   - 13 Hours ago
Technical analyst Todd Gordon sets his eyes on Amgen ahead of earnings.
  
    



BRIEF-AstraZeneca CEO says absolutely on track to meet mid and long-term targets   - 13 Hours ago
July 30 AstraZeneca CEO Pascal Soriot told reporters: * CEO says absolutely on track to meet mid and long-term targets * CEO says externalisation deal-making will continue in H2 * CFO says externalisation
  
    



Cardiome Pharma expects USD20.0m from higher bought deal financing   - 14 Hours ago
Pharmaceutical company Cardiome Pharma In conjunction with the offering, the underwriters have agreed to purchase, on a bought deal basis, 2,500,000 common shares from the treasury of the company at
  
    
*Votes may take up to 30 minutes to influence article rank order


Featured Members
John Griffith John Griffith
Pharma Industry
Larry Vaughn Larry Vaughn
Sr. Partner
Pharma Industry
Shannon Peryea Shannon Peryea
Vice President, Executive Recruiting
Pharma Industry
Joan Bradley Joan Bradley
President
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.